{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Carzelesin",
  "nciThesaurus": {
    "casRegistry": "119813-10-4",
    "chebiId": "",
    "chemicalFormula": "C41H37ClN6O5",
    "definition": "A cyclopropylpyrroloindole prodrug analogue and DNA minor groove binding agent, with antineoplastic activity.  After hydrolysis, the cyclopropyl group of carzelesin alkylates N3-adenine in a sequence-selective fashion. This results in tumor growth inhibition.",
    "fdaUniiCode": "668UF07O1P",
    "identifier": "C1441",
    "preferredName": "Carzelesin",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2156"
    ],
    "synonyms": [
      "2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-indol-5-yl)-6-(diethylamino)-, (S)-",
      "CARZELESIN",
      "Carzelesin",
      "U-80244",
      "carzelesin"
    ]
  }
}